28.42
Precedente Chiudi:
$26.48
Aprire:
$26.48
Volume 24 ore:
246.94K
Relative Volume:
0.88
Capitalizzazione di mercato:
$1.97B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+9.56%
1M Prestazione:
+32.12%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Alamar Biosciences Inc Stock (ALMR) Company Profile
Nome
Alamar Biosciences Inc
Settore
Industria
Telefono
510-626-9888
Indirizzo
47071 BAYSIDE PARKWAY, FREMONT
Compare ALMR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ALMR
Alamar Biosciences Inc
|
28.42 | 1.97B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc Borsa (ALMR) Ultime notizie
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling - riauone.com
AAIC 2026 逾 140 份学术报告均采用 Alamar Biosciences NULISA 数据,彰显阿尔茨海默病血液生物标志物分析领域的进展 - GlobeNewswire Inc.
Alamar’s platform to feature in 140+ presentations at AAIC - Investing.com India
Alamar Biosciences to Present NULISA Alzheimer’s Data in More Than 140 AAIC Posters and Sessions - Quiver Quantitative
New blood tests for Alzheimer’s take center stage at AAIC 2026 - Stock Titan
Form 13D/A Alamar Biosciences For: 7 July By Investing.com - Investing.com Nigeria
Sands Capital reports 6.1% Alamar Biosciences (ALMR) stake and board change - Stock Titan
Price to book forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences Launches First Commercial Blood-Based eMTBR-Tau Assay for Alzheimer’s Disease - Quiver Quantitative
Alamar puts Alzheimer’s tau tangle test into blood panels - Stock Titan
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research - wahanariau.com
Price to sales forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences Inc. (ALMR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Sherpa Funds Hold 7.2% of Alamar Biosciences (NASDAQ: ALMR) - Stock Titan
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Index - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Value Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 3000E Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Dynamic Index - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS:ALMR) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Alamar Biosciences Inc (ALMR:UW): Stock Price, Quote and News - BNN Bloomberg
Alamar Biosciences, Inc. (ALMR) Earnings Yield (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to S&P TMI Index - marketscreener.com
Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics - Koreabizwire
Alamar Biosciences Makes Home-Collected Fingerstick Samples - GlobeNewswire
Alamar Biosciences, Inc. (ALMR) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Number of shareholders of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Evaluating Alamar Biosciences (ALMR) Valuation As Shares Show Modest Year To Date Gains - Yahoo Finance
Alamar Biosciences, Inc. (ALMR) Net Income (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Liabilities - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash Equivalents (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Enterprise Value - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Equity (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Assets (TTM) - Zacks Investment Research
This Southwest Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
A Quick Look at Today's Ratings for Alamar Biosciences(ALMR.US), With a Forecast Between $27 to $35 - Moomoo
Stifel Initiates Alamar Biosciences at Buy With $28 Price Target - marketscreener.com
Leerink Initiates Alamar Biosciences at Outperform With $35 Price Target - marketscreener.com
Alamar Biosciences, Inc. (ALMR) Market Cap - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (TTM) - Zacks Investment Research
Stifel initiates Alamar Biosciences stock with buy rating - Investing.com UK
JPMorgan initiates Alamar Biosciences stock with overweight rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Alamar Biosciences stock with overweight rating - Investing.com India
Stifel initiates Alamar Biosciences stock with buy rating By Investing.com - Investing.com India
Alamar Biosciences, Inc. (ALMR) Gross Margin (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Assets (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Long Term Debt (Quarterly) - Zacks Investment Research
Alamar Biosciences Inc Azioni (ALMR) Dati Finanziari
Non sono disponibili dati finanziari per Alamar Biosciences Inc (ALMR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Alamar Biosciences Inc Azioni (ALMR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Naclerio Nicholas | Director |
Apr 20 '26 |
Buy |
17.00 |
235,294 |
3,999,998 |
507,076 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):